BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24618935)

  • 1. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
    Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology and clinical course of febrile neutropenia in children with cancer.
    Hakim H; Flynn PM; Knapp KM; Srivastava DK; Gaur AH
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):623-9. PubMed ID: 19644403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric fever in neutropenia with bacteremia-Pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study.
    Stergiotis M; Ammann RA; Droz S; Koenig C; Agyeman PKA
    PLoS One; 2021; 16(2):e0246654. PubMed ID: 33577566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
    Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
    Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
    Agyeman P; Aebi C; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Beck Popovic M; Leibundgut K; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2011 Jul; 30(7):e114-9. PubMed ID: 21394050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting fever in neutropenia with safety-relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study.
    Lavieri L; Koenig C; Bodmer N; Agyeman PKA; Scheinemann K; Ansari M; Roessler J; Ammann RA
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29253. PubMed ID: 34310027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Episodes of fever in neutropenia in pediatric patients with cancer in Bern, Switzerland, 1993-2012.
    Zermatten MG; Koenig C; von Allmen A; Agyeman P; Ammann RA
    Sci Data; 2019 Jan; 6():180304. PubMed ID: 30644854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Stream Infections and Antibiotic Utilization in Pediatric Leukemia Patients With Febrile Neutropenia.
    Reinecke J; Lowas S; Snowden J; Neemann K
    J Pediatr Hematol Oncol; 2019 May; 41(4):251-255. PubMed ID: 30095691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early hospital discharge of children with fever and neutropenia: a prospective study.
    Wacker P; Halperin DS; Wyss M; Humbert J
    J Pediatr Hematol Oncol; 1997; 19(3):208-11. PubMed ID: 9201142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of micafungin for febrile neutropenia in pediatric patients with hematological malignancies: a multicenter prospective study.
    Kobayashi R; Suzuki N; Yoshida M; Iizuka S; Suzuki D; Sano H; Kudoh T
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):e276-9. PubMed ID: 23743960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
    Hodgson-Viden H; Grundy PE; Robinson JL
    BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
    Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
    J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microbiological characteristics of pathogens causing bacteremia among hospitalized pediatric oncology patients with fever and neutropenia].
    Leibson T; Ben-Shimol S; Hazan G; Fruchtman Y; Kapelushnik J; Greenberg D
    Harefuah; 2012 Oct; 151(10):592-6, 603-4. PubMed ID: 23316669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk predictors for adverse outcome in pediatric febrile neutropenia: Single center experience from a low and middle-income country.
    Prasad M; Chinnaswamy G; Arora B; Vora T; Hawaldar R; Banavali S
    Indian J Cancer; 2014; 51(4):432-7. PubMed ID: 26842150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
    Wicki S; Keisker A; Aebi C; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2008 Dec; 51(6):778-83. PubMed ID: 18726920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.